tiprankstipranks
aTyr Pharma (ATYR)
NASDAQ:ATYR
US Market
ATYR
aTyr Pharma
RESEARCH TOOLSreports
Want to see ATYR full AI Analyst Report?

aTyr Pharma (ATYR) Income Statement

2,827 Followers

aTyr Pharma Income Statement

Last quarter (Q4 2025), aTyr Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, aTyr Pharma's net income was $-13.96M. See aTyr Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 190.00K$ 235.00K$ 353.00K$ 10.39M$ 0.00
Gross Profit
$ -1.36M$ 235.00K$ 353.00K$ 8.69M$ -1.30M
Operating Expenses
$ 76.26M$ 68.15M$ 55.27M$ 55.09M$ 32.71M
Depreciation and Amortization
$ 1.55M$ 1.54M$ 2.74M$ 1.70M$ 1.30M
EBITDA
$ -76.07M$ -66.37M$ -52.18M$ -44.71M$ -32.47M
Operating Income
$ -77.63M$ -67.91M$ -54.92M$ -46.40M$ -34.02M
Other Income/Expenses
$ 3.51M$ 3.89M$ 4.52M$ 1.06M$ 238.00K
Pretax Income
$ -74.12M$ -64.02M$ -50.40M$ -45.34M$ -33.78M
Net Income
$ -74.12M$ -64.02M$ -50.39M$ -45.34M$ -33.77M
Per Share Metrics
Basic EPS
$ -0.80$ -0.86$ -0.94$ -1.60$ -1.77
Diluted EPS
$ -0.80$ -0.86$ -0.94$ -1.60$ -1.77
Weighted Average Shares Outstanding
 92.99M 74.26M 53.61M 28.42M 19.08M
Weighted Average Shares Outstanding (Diluted)
 92.99M 74.26M 53.61M 28.42M 19.08M
Currency in USD

aTyr Pharma Earnings and Revenue History